United States Food and Drug Administration TASS Program
I read with interest the article by Eydelman et al announcing the Food and Drug Administration's (FDAs) proactive toxic anterior segment syndrome program, as well the accompanying editorial by Gottsch and Schein. The article and the editorial describe the FDA's establishment of a proactive initiative for testing potential causes of TASS, as well as the development of tools to collect data, standardize devices, and improve communication among those involved in analyzing TASS cases. Unfortunately, these articles omit any acknowledgement or mention of the involvement of the American Society of Cataract (Read more...)